Shortenhaus, Lilly Oncology, PACE Program Beckie VonRuden, Mayo Clinic Cancer Center, Patient Perspective On-site demonstrations of the following value tools were available to attendees: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
Search Results
Harold J. Burstein
choice by prior NCCN guidance on advanced colorectal cancer. 2 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer 2 had endorsed FOLFIRI as second-line therapy for advanced colorectal cancer, with or without ziv
quality, effective, efficient, and accessible cancer care so patients can live better lives under any circumstances. The organization has continued posting new updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)—which contain
to imaging recommendations, adapted from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) “Through our collaboration with NDSC, providers and their patients with cancer can benefit from access to NCCN Guidelines-based, qualified
-sharing, as well as “administrative guidance” to put each recommendation into context. Recommendations incorporate evidence-based clinical information from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), when applicable, and from other
expert insights into the consideration and decision-making processes that result in the recommendations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and perspectives from regulatory and reimbursement experts on current trends and
NCCN Announces New Addition to Library of Guidelines: NCCN Guidelines for Lung Cancer Screening NCCN announces the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening, a new addition to the Complete
(MENA) region gathered in Doha, Qatar, for 3 days of intensive education and discussion surrounding the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and their application in MENA practices. Dr. Hamdy Azim of Cairo University opened the
Templates is derived from the recommendations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), recognized as the standard for clinical policy in the oncology community, and the NCCN Drugs & Biologics Compendium (NCCN Compendium
Steven Sorscher
community physician. We welcome comments about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), articles published in the journal, or any other topic relating to cancer prevention, detection, treatment, supportive care, or survivorship